reported that in ovarian cancer, ANRIL could interact with let-7a to further reduce HMGA2 levels, which promoted the apoptosis and improved the cisplatin sensitivity of ovarian cancer cells. The gene discussed is CDKN2B-AS1; the disease is ovarian carcinoma.